Genentech DRC A MULTICENTER, RANDOMIZED, VISUAL ASSESSOR-MASKED, ACTIVE-COMPARATOR STUDY OF THE EFFICACY, SAFETY, AND PHARMACOKINETICS OF THE PORT DELIVERY SYSTEM WITH RANIBIZUMAB IN PATIENTS WITH DIABETIC RETINOPATHY WITH OR WITHOUT DME
Research Grant
Administered By
Ophthalmology
Awarded By
Genentech, Inc.
Start Date
July 4, 2020
End Date
December 31, 2024
Administered By
Ophthalmology
Awarded By
Genentech, Inc.
Start Date
July 4, 2020
End Date
December 31, 2024